{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This notebook documents the process of parsing the json drug label files from openFDA"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "import zipfile\n",
    "import glob\n",
    "import time\n",
    "import itertools\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "%matplotlib inline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "../../data/ exists\n",
      "../../data/downloads/ exists\n",
      "../../data/parsed/ exists\n",
      "../../data/parsed/meta/ exists\n"
     ]
    }
   ],
   "source": [
    "data_dir=\"../../data/\"\n",
    "try:\n",
    "    os.mkdir(data_dir)\n",
    "except:\n",
    "    print(data_dir+' exists')\n",
    "downloads_dir=data_dir+\"downloads/\"\n",
    "try:\n",
    "    os.mkdir(downloads_dir)\n",
    "except:\n",
    "    print(downloads_dir+' exists')\n",
    "    \n",
    "out = data_dir+\"parsed/\"\n",
    "try:\n",
    "    os.mkdir(out)\n",
    "except:\n",
    "    print(out+' exists')\n",
    "out_meta = out+\"meta/\"\n",
    "try:\n",
    "    os.mkdir(out_meta)\n",
    "except:\n",
    "    print(out_meta+' exists')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "drug_label_files = glob.glob(downloads_dir+\"*.json.zip\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "drug-label-0003-of-0009.json\n",
      "Parsing...\n",
      "15.0  seconds\n",
      "drug-label-0008-of-0009.json\n",
      "Parsing...\n",
      "14.48  seconds\n",
      "drug-label-0007-of-0009.json\n",
      "Parsing...\n",
      "14.46  seconds\n",
      "drug-label-0002-of-0009.json\n",
      "Parsing...\n",
      "15.05  seconds\n",
      "drug-label-0009-of-0009.json\n",
      "Parsing...\n",
      "10.47  seconds\n",
      "drug-label-0006-of-0009.json\n",
      "Parsing...\n",
      "15.52  seconds\n",
      "drug-label-0001-of-0009.json\n",
      "Parsing...\n",
      "14.91  seconds\n",
      "drug-label-0005-of-0009.json\n",
      "Parsing...\n",
      "15.53  seconds\n",
      "drug-label-0004-of-0009.json\n",
      "Parsing...\n",
      "16.41  seconds\n"
     ]
    }
   ],
   "source": [
    "dfs = []\n",
    "drug_label_file = drug_label_files[0]\n",
    "for drug_label_file in drug_label_files:\n",
    "    z = zipfile.ZipFile(drug_label_file, \"r\")\n",
    "    for filename in z.namelist():   \n",
    "        t0 = time.time()\n",
    "\n",
    "        print(filename) \n",
    "        file_lst = filename.split('.')\n",
    "        out_file = '_'.join(file_lst[:1])\n",
    "        with z.open(filename) as f:  \n",
    "            data = f.read()  \n",
    "            d = json.loads(data.decode(\"utf-8\"))\n",
    "\n",
    "            meta = pd.json_normalize(d['meta'])\n",
    "            (meta.\n",
    "             to_csv(out_meta+out_file+'_meta.csv.gzip',\n",
    "                        compression='gzip'))\n",
    "            \n",
    "            results = pd.json_normalize(d['results'])\n",
    "            results.index = results['set_id'].values\n",
    "            \n",
    "            print('Parsing...')\n",
    "            t0 = time.time()\n",
    "            subs = []\n",
    "            #fields = results.columns.sort_values().values\n",
    "            fields = ['openfda.rxcui',\n",
    "                      'openfda.unii',\n",
    "                      'effective_time',\n",
    "                      'animal_pharmacology_and_or_toxicology',\n",
    "                     'keep_out_of_reach_of_children',\n",
    "                      'pediatric_use'\n",
    "                     ]\n",
    "            n=results.shape[0]\n",
    "            for field in fields:\n",
    "                sub = \\\n",
    "                (pd.concat(\n",
    "                    {k: pd.Series(v) for k, v in results.head(n)[field].items()}\n",
    "                ).\n",
    "                 reset_index().\n",
    "                 drop('level_1',axis=1).\n",
    "                 rename(columns={'level_0' : 'set_id',0 : field}).\n",
    "                 set_index('set_id')\n",
    "                )\n",
    "                subs.append(sub)\n",
    "\n",
    "            df = pd.concat(subs, axis=0)\n",
    "            t1 = time.time()\n",
    "            print(np.round(t1-t0,2),' seconds')\n",
    "            \n",
    "            dfs.append(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.concat(dfs).sort_values('effective_time').reset_index().groupby('set_id').last()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>openfda.rxcui</th>\n",
       "      <th>openfda.unii</th>\n",
       "      <th>effective_time</th>\n",
       "      <th>animal_pharmacology_and_or_toxicology</th>\n",
       "      <th>keep_out_of_reach_of_children</th>\n",
       "      <th>pediatric_use</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>set_id</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0000025c-6dbf-4af7-a741-5cbacaed519a</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20151102</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Keep this and all medication out of reach of c...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0000076a-fc39-4208-ace8-6c2cb367904f</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20150109</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Keep out of reach of children If product is sw...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>00006ebc-ec2b-406c-96b7-a3cc422e933f</th>\n",
       "      <td>NaN</td>\n",
       "      <td>X2N6E405GV</td>\n",
       "      <td>20180801</td>\n",
       "      <td>NaN</td>\n",
       "      <td>KEEP OUT OF REACH OF CHILDREN Keep this and al...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>00011703-bc55-4c0c-858c-149dc674bc3c</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20171230</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pediatric use: Safety and effectiveness in inf...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>000155a8-709c-44e5-a75f-cd890f3a7caf</th>\n",
       "      <td>198014</td>\n",
       "      <td>57Y76R9ATQ</td>\n",
       "      <td>20190124</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8.4 Pediatric Use Safety and effectiveness in ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     openfda.rxcui openfda.unii  \\\n",
       "set_id                                                            \n",
       "0000025c-6dbf-4af7-a741-5cbacaed519a           NaN          NaN   \n",
       "0000076a-fc39-4208-ace8-6c2cb367904f           NaN          NaN   \n",
       "00006ebc-ec2b-406c-96b7-a3cc422e933f           NaN   X2N6E405GV   \n",
       "00011703-bc55-4c0c-858c-149dc674bc3c           NaN          NaN   \n",
       "000155a8-709c-44e5-a75f-cd890f3a7caf        198014   57Y76R9ATQ   \n",
       "\n",
       "                                     effective_time  \\\n",
       "set_id                                                \n",
       "0000025c-6dbf-4af7-a741-5cbacaed519a       20151102   \n",
       "0000076a-fc39-4208-ace8-6c2cb367904f       20150109   \n",
       "00006ebc-ec2b-406c-96b7-a3cc422e933f       20180801   \n",
       "00011703-bc55-4c0c-858c-149dc674bc3c       20171230   \n",
       "000155a8-709c-44e5-a75f-cd890f3a7caf       20190124   \n",
       "\n",
       "                                     animal_pharmacology_and_or_toxicology  \\\n",
       "set_id                                                                       \n",
       "0000025c-6dbf-4af7-a741-5cbacaed519a                                   NaN   \n",
       "0000076a-fc39-4208-ace8-6c2cb367904f                                   NaN   \n",
       "00006ebc-ec2b-406c-96b7-a3cc422e933f                                   NaN   \n",
       "00011703-bc55-4c0c-858c-149dc674bc3c                                   NaN   \n",
       "000155a8-709c-44e5-a75f-cd890f3a7caf                                   NaN   \n",
       "\n",
       "                                                          keep_out_of_reach_of_children  \\\n",
       "set_id                                                                                    \n",
       "0000025c-6dbf-4af7-a741-5cbacaed519a  Keep this and all medication out of reach of c...   \n",
       "0000076a-fc39-4208-ace8-6c2cb367904f  Keep out of reach of children If product is sw...   \n",
       "00006ebc-ec2b-406c-96b7-a3cc422e933f  KEEP OUT OF REACH OF CHILDREN Keep this and al...   \n",
       "00011703-bc55-4c0c-858c-149dc674bc3c                                                NaN   \n",
       "000155a8-709c-44e5-a75f-cd890f3a7caf                                                NaN   \n",
       "\n",
       "                                                                          pediatric_use  \n",
       "set_id                                                                                   \n",
       "0000025c-6dbf-4af7-a741-5cbacaed519a                                                NaN  \n",
       "0000076a-fc39-4208-ace8-6c2cb367904f                                                NaN  \n",
       "00006ebc-ec2b-406c-96b7-a3cc422e933f                                                NaN  \n",
       "00011703-bc55-4c0c-858c-149dc674bc3c  Pediatric use: Safety and effectiveness in inf...  \n",
       "000155a8-709c-44e5-a75f-cd890f3a7caf  8.4 Pediatric Use Safety and effectiveness in ...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "# unique labels:  173318\n",
      "# unique labels with  openfda.rxcui :  53079\n",
      "% labels with  openfda.rxcui :  0.3062520915311739\n",
      "# unique labels with  openfda.unii :  90273\n",
      "% labels with  openfda.unii :  0.5208518445862519\n",
      "# unique labels with  effective_time :  173318\n",
      "% labels with  effective_time :  1.0\n",
      "# unique labels with  animal_pharmacology_and_or_toxicology :  7551\n",
      "% labels with  animal_pharmacology_and_or_toxicology :  0.043567315570223517\n",
      "# unique labels with  keep_out_of_reach_of_children :  104989\n",
      "% labels with  keep_out_of_reach_of_children :  0.6057593556353063\n",
      "# unique labels with  pediatric_use :  46403\n",
      "% labels with  pediatric_use :  0.2677332994841851\n"
     ]
    }
   ],
   "source": [
    "display(df.head())\n",
    "print(\"# unique labels: \",df.index.nunique())\n",
    "for f in df.columns:\n",
    "    print(\"# unique labels with \",f,\": \",df.dropna(subset=[f]).index.nunique())\n",
    "    print(\"% labels with \",f,\": \",df.dropna(subset=[f]).index.nunique()/df.index.nunique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(20000, 163)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>package_label_principal_display_panel</th>\n",
       "      <th>description</th>\n",
       "      <th>effective_time</th>\n",
       "      <th>spl_product_data_elements</th>\n",
       "      <th>version</th>\n",
       "      <th>warnings_and_cautions</th>\n",
       "      <th>id</th>\n",
       "      <th>set_id</th>\n",
       "      <th>carcinogenesis_and_mutagenesis_and_impairment_of_fertility</th>\n",
       "      <th>pregnancy</th>\n",
       "      <th>...</th>\n",
       "      <th>components</th>\n",
       "      <th>teratogenic_effects_table</th>\n",
       "      <th>food_safety_warning</th>\n",
       "      <th>drug_and_or_laboratory_test_interactions_table</th>\n",
       "      <th>nonteratogenic_effects_table</th>\n",
       "      <th>accessories</th>\n",
       "      <th>troubleshooting</th>\n",
       "      <th>assembly_or_installation_instructions</th>\n",
       "      <th>environmental_warning</th>\n",
       "      <th>summary_of_safety_and_effectiveness</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9367137e-200c-48c6-9634-135e1faeb101</th>\n",
       "      <td>[LABEL IMAGE LABEL IMAGE]</td>\n",
       "      <td>[DESCRIPTION Phenytoin sodium is an antiepilep...</td>\n",
       "      <td>20100219</td>\n",
       "      <td>[PHENYTOIN ER PHENYTOIN SODIUM PHENYTOIN SODIU...</td>\n",
       "      <td>1</td>\n",
       "      <td>[CLINICAL PHARMACOLOGY Phenytoin is an antiepi...</td>\n",
       "      <td>c4783156-8357-488d-aaf4-83b1e5978529</td>\n",
       "      <td>9367137e-200c-48c6-9634-135e1faeb101</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51132e43-6fda-4cd4-a818-cfd399264e89</th>\n",
       "      <td>[PACKAGE LABEL.PRINCIPAL DISPLAY PANEL- 250 mg...</td>\n",
       "      <td>[DESCRIPTION Divalproex sodium is a stable co-...</td>\n",
       "      <td>20131229</td>\n",
       "      <td>[Divalproex Sodium Divalproex Sodium DIVALPROE...</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>c587a83e-6bd2-4645-8044-0884fbb2bc4f</td>\n",
       "      <td>51132e43-6fda-4cd4-a818-cfd399264e89</td>\n",
       "      <td>[Carcinogenesis, Mutagenesis, Impairment of Fe...</td>\n",
       "      <td>[Pregnancy Pregnancy category D See WARNINGS ....</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded</th>\n",
       "      <td>[500 mL]</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20200713</td>\n",
       "      <td>[BioMiracle staysafe HAND SANITIZER ALCOHOL GL...</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>aa5fa38b-80a4-0d53-e053-2995a90a8de1</td>\n",
       "      <td>aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>a062586b-fc78-462c-848d-bc11d06b421d</th>\n",
       "      <td>[nm-good-mood-enhancer.jpg]</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20200714</td>\n",
       "      <td>[Good Mood Enhancer Agrimonia eupatoria, flos,...</td>\n",
       "      <td>3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>aa6b1be3-4086-4789-e053-2a95a90a0a7a</td>\n",
       "      <td>a062586b-fc78-462c-848d-bc11d06b421d</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>aa6bf8e8-9287-0ea1-e053-2a95a90a1d08</th>\n",
       "      <td>[Package Label - Principal Display Panel 3785....</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20200714</td>\n",
       "      <td>[Hand Sanitizer ALCOHOL TROLAMINE ALOE VERA LE...</td>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>aa6bf8e8-9279-0ea1-e053-2a95a90a1d08</td>\n",
       "      <td>aa6bf8e8-9287-0ea1-e053-2a95a90a1d08</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 163 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  package_label_principal_display_panel  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101                          [LABEL IMAGE LABEL IMAGE]   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89  [PACKAGE LABEL.PRINCIPAL DISPLAY PANEL- 250 mg...   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded                                           [500 mL]   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d                        [nm-good-mood-enhancer.jpg]   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08  [Package Label - Principal Display Panel 3785....   \n",
       "\n",
       "                                                                            description  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101  [DESCRIPTION Phenytoin sodium is an antiepilep...   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89  [DESCRIPTION Divalproex sodium is a stable co-...   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded                                                NaN   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d                                                NaN   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08                                                NaN   \n",
       "\n",
       "                                     effective_time  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101       20100219   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89       20131229   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded       20200713   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d       20200714   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08       20200714   \n",
       "\n",
       "                                                              spl_product_data_elements  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101  [PHENYTOIN ER PHENYTOIN SODIUM PHENYTOIN SODIU...   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89  [Divalproex Sodium Divalproex Sodium DIVALPROE...   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded  [BioMiracle staysafe HAND SANITIZER ALCOHOL GL...   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d  [Good Mood Enhancer Agrimonia eupatoria, flos,...   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08  [Hand Sanitizer ALCOHOL TROLAMINE ALOE VERA LE...   \n",
       "\n",
       "                                     version  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101       1   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89       1   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded       1   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d       3   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08       1   \n",
       "\n",
       "                                                                  warnings_and_cautions  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101  [CLINICAL PHARMACOLOGY Phenytoin is an antiepi...   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89                                                NaN   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded                                                NaN   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d                                                NaN   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08                                                NaN   \n",
       "\n",
       "                                                                        id  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101  c4783156-8357-488d-aaf4-83b1e5978529   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89  c587a83e-6bd2-4645-8044-0884fbb2bc4f   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded  aa5fa38b-80a4-0d53-e053-2995a90a8de1   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d  aa6b1be3-4086-4789-e053-2a95a90a0a7a   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08  aa6bf8e8-9279-0ea1-e053-2a95a90a1d08   \n",
       "\n",
       "                                                                    set_id  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101  9367137e-200c-48c6-9634-135e1faeb101   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89  51132e43-6fda-4cd4-a818-cfd399264e89   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded  aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d  a062586b-fc78-462c-848d-bc11d06b421d   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08  aa6bf8e8-9287-0ea1-e053-2a95a90a1d08   \n",
       "\n",
       "                                     carcinogenesis_and_mutagenesis_and_impairment_of_fertility  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101                                                NaN           \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89  [Carcinogenesis, Mutagenesis, Impairment of Fe...           \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded                                                NaN           \n",
       "a062586b-fc78-462c-848d-bc11d06b421d                                                NaN           \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08                                                NaN           \n",
       "\n",
       "                                                                              pregnancy  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101                                                NaN   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89  [Pregnancy Pregnancy category D See WARNINGS ....   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded                                                NaN   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d                                                NaN   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08                                                NaN   \n",
       "\n",
       "                                      ... components  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101  ...        NaN   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89  ...        NaN   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded  ...        NaN   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d  ...        NaN   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08  ...        NaN   \n",
       "\n",
       "                                     teratogenic_effects_table  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101                       NaN   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89                       NaN   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded                       NaN   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d                       NaN   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08                       NaN   \n",
       "\n",
       "                                     food_safety_warning  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101                 NaN   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89                 NaN   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded                 NaN   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d                 NaN   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08                 NaN   \n",
       "\n",
       "                                     drug_and_or_laboratory_test_interactions_table  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101                                            NaN   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89                                            NaN   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded                                            NaN   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d                                            NaN   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08                                            NaN   \n",
       "\n",
       "                                     nonteratogenic_effects_table accessories  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101                          NaN         NaN   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89                          NaN         NaN   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded                          NaN         NaN   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d                          NaN         NaN   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08                          NaN         NaN   \n",
       "\n",
       "                                     troubleshooting  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101             NaN   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89             NaN   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded             NaN   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d             NaN   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08             NaN   \n",
       "\n",
       "                                     assembly_or_installation_instructions  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101                                   NaN   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89                                   NaN   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded                                   NaN   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d                                   NaN   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08                                   NaN   \n",
       "\n",
       "                                     environmental_warning  \\\n",
       "9367137e-200c-48c6-9634-135e1faeb101                   NaN   \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89                   NaN   \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded                   NaN   \n",
       "a062586b-fc78-462c-848d-bc11d06b421d                   NaN   \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08                   NaN   \n",
       "\n",
       "                                     summary_of_safety_and_effectiveness  \n",
       "9367137e-200c-48c6-9634-135e1faeb101                                 NaN  \n",
       "51132e43-6fda-4cd4-a818-cfd399264e89                                 NaN  \n",
       "aa5fa6bc-87ba-4e8c-e053-2a95a90a7ded                                 NaN  \n",
       "a062586b-fc78-462c-848d-bc11d06b421d                                 NaN  \n",
       "aa6bf8e8-9287-0ea1-e053-2a95a90a1d08                                 NaN  \n",
       "\n",
       "[5 rows x 163 columns]"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print(results.shape)\n",
    "results.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['abuse', 'accessories', 'active_ingredient',\n",
       "       'active_ingredient_table', 'adverse_reactions',\n",
       "       'adverse_reactions_table', 'animal_pharmacology_and_or_toxicology',\n",
       "       'animal_pharmacology_and_or_toxicology_table', 'ask_doctor',\n",
       "       'ask_doctor_or_pharmacist', 'ask_doctor_or_pharmacist_table',\n",
       "       'ask_doctor_table', 'assembly_or_installation_instructions',\n",
       "       'boxed_warning', 'boxed_warning_table',\n",
       "       'carcinogenesis_and_mutagenesis_and_impairment_of_fertility',\n",
       "       'carcinogenesis_and_mutagenesis_and_impairment_of_fertility_table',\n",
       "       'cleaning', 'clinical_pharmacology', 'clinical_pharmacology_table',\n",
       "       'clinical_studies', 'clinical_studies_table', 'components',\n",
       "       'contraindications', 'contraindications_table',\n",
       "       'controlled_substance', 'dependence', 'description',\n",
       "       'description_table', 'disposal_and_waste_handling', 'do_not_use',\n",
       "       'do_not_use_table', 'dosage_and_administration',\n",
       "       'dosage_and_administration_table', 'dosage_forms_and_strengths',\n",
       "       'dosage_forms_and_strengths_table', 'drug_abuse_and_dependence',\n",
       "       'drug_abuse_and_dependence_table',\n",
       "       'drug_and_or_laboratory_test_interactions',\n",
       "       'drug_and_or_laboratory_test_interactions_table',\n",
       "       'drug_interactions', 'drug_interactions_table', 'effective_time',\n",
       "       'environmental_warning', 'food_safety_warning',\n",
       "       'general_precautions', 'general_precautions_table',\n",
       "       'geriatric_use', 'geriatric_use_table',\n",
       "       'health_care_provider_letter', 'health_care_provider_letter_table',\n",
       "       'health_claim', 'health_claim_table', 'how_supplied',\n",
       "       'how_supplied_table', 'id', 'inactive_ingredient',\n",
       "       'inactive_ingredient_table', 'indications_and_usage',\n",
       "       'indications_and_usage_table',\n",
       "       'information_for_owners_or_caregivers',\n",
       "       'information_for_owners_or_caregivers_table',\n",
       "       'information_for_patients', 'information_for_patients_table',\n",
       "       'instructions_for_use', 'instructions_for_use_table',\n",
       "       'intended_use_of_the_device', 'keep_out_of_reach_of_children',\n",
       "       'keep_out_of_reach_of_children_table', 'labor_and_delivery',\n",
       "       'laboratory_tests', 'laboratory_tests_table',\n",
       "       'mechanism_of_action', 'mechanism_of_action_table', 'microbiology',\n",
       "       'microbiology_table', 'nonclinical_toxicology',\n",
       "       'nonclinical_toxicology_table', 'nonteratogenic_effects',\n",
       "       'nonteratogenic_effects_table', 'nursing_mothers',\n",
       "       'openfda.application_number', 'openfda.brand_name',\n",
       "       'openfda.generic_name', 'openfda.is_original_packager',\n",
       "       'openfda.manufacturer_name', 'openfda.nui',\n",
       "       'openfda.original_packager_product_ndc', 'openfda.package_ndc',\n",
       "       'openfda.pharm_class_cs', 'openfda.pharm_class_epc',\n",
       "       'openfda.pharm_class_moa', 'openfda.pharm_class_pe',\n",
       "       'openfda.product_ndc', 'openfda.product_type', 'openfda.route',\n",
       "       'openfda.rxcui', 'openfda.spl_id', 'openfda.spl_set_id',\n",
       "       'openfda.substance_name', 'openfda.unii', 'openfda.upc',\n",
       "       'other_safety_information', 'overdosage', 'overdosage_table',\n",
       "       'package_label_principal_display_panel',\n",
       "       'package_label_principal_display_panel_table',\n",
       "       'patient_medication_information',\n",
       "       'patient_medication_information_table', 'pediatric_use',\n",
       "       'pediatric_use_table', 'pharmacodynamics',\n",
       "       'pharmacodynamics_table', 'pharmacogenomics', 'pharmacokinetics',\n",
       "       'pharmacokinetics_table', 'precautions', 'precautions_table',\n",
       "       'pregnancy', 'pregnancy_or_breast_feeding',\n",
       "       'pregnancy_or_breast_feeding_table', 'pregnancy_table', 'purpose',\n",
       "       'purpose_table', 'questions', 'questions_table',\n",
       "       'recent_major_changes', 'recent_major_changes_table', 'references',\n",
       "       'references_table', 'risks', 'route', 'safe_handling_warning',\n",
       "       'safe_handling_warning_table', 'set_id',\n",
       "       'spl_indexing_data_elements', 'spl_medguide', 'spl_medguide_table',\n",
       "       'spl_patient_package_insert', 'spl_patient_package_insert_table',\n",
       "       'spl_product_data_elements', 'spl_unclassified_section',\n",
       "       'spl_unclassified_section_table', 'statement_of_identity',\n",
       "       'statement_of_identity_table', 'stop_use', 'stop_use_table',\n",
       "       'storage_and_handling', 'storage_and_handling_table',\n",
       "       'summary_of_safety_and_effectiveness', 'teratogenic_effects',\n",
       "       'teratogenic_effects_table', 'troubleshooting',\n",
       "       'use_in_specific_populations', 'use_in_specific_populations_table',\n",
       "       'user_safety_warnings', 'version', 'veterinary_indications',\n",
       "       'warnings', 'warnings_and_cautions', 'warnings_and_cautions_table',\n",
       "       'warnings_table', 'when_using'], dtype=object)"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results.columns.sort_values().values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.5, 1.0, 'Label field NA distribution for 1 of 9 samples')"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.hist(results.apply(lambda x : x.isna().sum(),1).sort_values().values,bins=100)\n",
    "plt.xlabel(\"Number of NAs\")\n",
    "plt.ylabel(\"Number of labels\")\n",
    "plt.title(\"Label field NA distribution for 1 of 9 samples\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.5, 1.0, 'Label field NA distribution for 1 of 9 samples')"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.hist(results.apply(lambda x : x.isna().sum(),0).sort_values().values,bins=100)\n",
    "plt.xlabel(\"Number of labels\")\n",
    "plt.ylabel(\"Number of NA fields\")\n",
    "plt.title(\"Label field NA distribution for 1 of 9 samples\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Pediatric Use Safety and effectiveness in pediatric patients have not been established.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             2842\n",
       "8.4 Pediatric Use Safety and effectiveness in pediatric patients have not been established.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          918\n",
       "Pediatric Use: Safety and effectiveness in pediatric patients have not been established.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             460\n",
       "Pediatric Use Safety and effectiveness in children have not been established.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        350\n",
       "8.4 Pediatric Use Safety and effectiveness have not been established in pediatric patients.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          212\n",
       "Pediatric Use Safety and effectiveness of propranolol in pediatric patients have not been established. Bronchospasm and congestive heart failure have been reported coincident with the administration of propranolol therapy in pediatric patients.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 182\n",
       "Pediatric Use Safety and effectiveness in pediatric patients below the age of 12 have not been established.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          170\n",
       "Pediatric Use The efficacy and safety of corticosteroids in the pediatric population are based on the well-established course of effect of corticosteroids, which is similar in pediatric and adult populations. Published studies provide evidence of efficacy and safety in pediatric patients for the treatment of nephrotic syndrome (patients >2 years of age), and aggressive lymphomas and leukemias (patients >1 month of age). Other indications for pediatric use of corticosteroids, e.g., severe asthma and wheezing, are based on adequate and well-controlled trials conducted in adults, on the premises that the course of the diseases and their pathophysiology are considered to be substantially similar in both populations. The adverse effects of corticosteroids in pediatric patients are similar to those in adults (see ADVERSE REACTIONS ). Like adults, pediatric patients should be carefully observed with frequent measurements of blood pressure, weight, height, intraocular pressure, and clinical evaluation for the presence of infection, psychosocial disturbances, thromboembolism, peptic ulcers, cataracts, and osteoporosis. Pediatric patients who are treated with corticosteroids by any route, including systemically administered corticosteroids, may experience a decrease in their growth velocity. This negative impact of corticosteroids on growth has been observed at low systemic doses and in the absence of laboratory evidence of hypothalamic-pituitary-adrenal (HPA) axis suppression (i.e., cosyntropin stimulation and basal cortisol plasma levels). Growth velocity may therefore be a more sensitive indicator of systemic corticosteroid exposure in pediatric patients than some commonly used tests of HPA axis function. The linear growth of pediatric patients treated with corticosteroids should be monitored, and the potential growth effects of prolonged treatment should be weighed against clinical benefits obtained and the availability of treatment alternatives. In order to minimize the potential growth effects of corticosteroids, pediatric patients should be titrated to the lowest effective dose.     169\n",
       "Pediatric Use Safety and effectiveness of oral formulations of acyclovir in pediatric patients younger than 2 years of age have not been established.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                166\n",
       "Pediatric Use Safety and effectiveness of alprazolam in individuals below 18 years of age have not been established.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 145\n",
       "Name: pediatric_use, dtype: int64"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['pediatric_use'].value_counts().head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True     28995\n",
       "False    17408\n",
       "Name: pediatric_use, dtype: int64"
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['pediatric_use'].str.contains('have not been established').value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Pediatric Use The efficacy and safety of corticosteroids in the pediatric population are based on the well-established course of effect of corticosteroids, which is similar in pediatric and adult populations. Published studies provide evidence of efficacy and safety in pediatric patients for the treatment of nephrotic syndrome (patients >2 years of age), and aggressive lymphomas and leukemias (patients >1 month of age). Other indications for pediatric use of corticosteroids, e.g., severe asthma and wheezing, are based on adequate and well-controlled trials conducted in adults, on the premises that the course of the diseases and their pathophysiology are considered to be substantially similar in both populations. The adverse effects of corticosteroids in pediatric patients are similar to those in adults (see ADVERSE REACTIONS ). Like adults, pediatric patients should be carefully observed with frequent measurements of blood pressure, weight, height, intraocular pressure, and clinical evaluation for the presence of infection, psychosocial disturbances, thromboembolism, peptic ulcers, cataracts, and osteoporosis. Pediatric patients who are treated with corticosteroids by any route, including systemically administered corticosteroids, may experience a decrease in their growth velocity. This negative impact of corticosteroids on growth has been observed at low systemic doses and in the absence of laboratory evidence of hypothalamic-pituitary-adrenal (HPA) axis suppression (i.e., cosyntropin stimulation and basal cortisol plasma levels). Growth velocity may therefore be a more sensitive indicator of systemic corticosteroid exposure in pediatric patients than some commonly used tests of HPA axis function. The linear growth of pediatric patients treated with corticosteroids should be monitored, and the potential growth effects of prolonged treatment should be weighed against clinical benefits obtained and the availability of treatment alternatives. In order to minimize the potential growth effects of corticosteroids, pediatric patients should be titrated to the lowest effective dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               169\n",
       "8.4 Pediatric Use Because of incompletely developed renal function in neonates and young infants, the elimination of amoxicillin may be delayed. Dosing of amoxicillin should be modified in pediatric patients 12 weeks or younger (â‰¤ 3 months). [See Dosage and Administration (2.2) .]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      137\n",
       "8.4 Pediatric Use Adequate and well-controlled studies with warfarin sodium have not been conducted in any pediatric population, and the optimum dosing, safety, and efficacy in pediatric patients is unknown. Pediatric use of warfarin sodium is based on adult data and recommendations, and available limited pediatric data from observational studies and patient registries. Pediatric patients administered warfarin sodium should avoid any activity or sport that may result in traumatic injury. The developing hemostatic system in infants and children results in a changing physiology of thrombosis and response to anticoagulants. Dosing of warfarin in the pediatric population varies by patient age, with infants generally having the highest, and adolescents having the lowest milligram per kilogram dose requirements to maintain target INRs. Because of changing warfarin requirements due to age, concomitant medications, diet, and existing medical condition, target INR ranges may be difficult to achieve and maintain in pediatric patients, and more frequent INR determinations are recommended. Bleeding rates varied by patient population and clinical care center in pediatric observational studies and patient registries. Infants and children receiving vitamin K-supplemented nutrition, including infant formulas, may be resistant to warfarin therapy, while human milk-fed infants may be sensitive to warfarin therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    122\n",
       "Pediatric Use General The goal of treatment in pediatric patients with hypothyroidism is to achieve and maintain normal intellectual and physical growth and development. The initial dose of levothyroxine varies with age and body weight (see DOSAGE AND ADMINISTRATION , Table 3 ). Dosing adjustments are based on an assessment of the individual patient's clinical and laboratory parameters (see PRECAUTIONS, Laboratory Tests ). In children in whom a diagnosis of permanent hypothyroidism has not been established, it is recommended that levothyroxine administration be discontinued for a 30-day trial period, but only after the child is at least 3 years of age. Serum T 4 and TSH levels should then be obtained. If the T 4 is low and the TSH high, the diagnosis of permanent hypothyroidism is established, and levothyroxine therapy should be reinstituted. If the T 4 and TSH levels are normal, euthyroidism may be assumed and, therefore, the hypothyroidism can be considered to have been transient. In this instance, however, the physician should carefully monitor the child and repeat the thyroid function tests if any signs or symptoms of hypothyroidism develop. In this setting, the clinician should have a high index of suspicion of relapse. If the results of the levothyroxine withdrawal test are inconclusive, careful follow-up and subsequent testing will be necessary. Since some more severely affected children may become clinically hypothyroid when treatment is discontinued for 30 days, an alternate approach is to reduce the replacement dose of levothyroxine by half during the 30-day trial period. If, after 30 days, the serum TSH is elevated above 20 mU/L, the diagnosis of permanent hypothyroidism is confirmed, and full replacement therapy should be resumed. However, if the serum TSH has not risen to greater than 20 mU/L, levothyroxine treatment should be discontinued for another 30-day trial period followed by repeat serum T 4 and TSH. The presence of concomitant medical conditions should be considered in certain clinical circumstances and, if present, appropriately treated (see PRECAUTIONS ). Congenital Hypothyroidism (see PRECAUTIONS, Laboratory Tests and DOSAGE AND ADMINISTRATION ) Rapid restoration of normal serum T 4 concentrations is essential for preventing the adverse effects of congenital hypothyroidism on intellectual development as well as on overall physical growth and maturation. Therefore, Levothyroxine Sodium Tablets, USP therapy should be initiated immediately upon diagnosis and is generally continued for life. During the first 2 weeks of Levothyroxine Sodium Tablets, USP therapy, infants should be closely monitored for cardiac overload, arrhythmias, and aspiration from avid suckling. The patient should be monitored closely to avoid undertreatment or overtreatment. Undertreatment may have deleterious effects on intellectual development and linear growth. Overtreatment has been associated with craniosynostosis in infants, and may adversely affect the tempo of brain maturation and accelerate the bone age with resultant premature closure of the epiphyses and compromised adult stature. Acquired Hypothyroidism in Pediatric Patients The patient should be monitored closely to avoid undertreatment and overtreatment. Undertreatment may result in poor school performance due to impaired concentration and slowed mentation and in reduced adult height. Overtreatment may accelerate the bone age and result in premature epiphyseal closure and compromised adult stature. Treated children may manifest a period of catch-up growth, which may be adequate in some cases to normalize adult height. In children with severe or prolonged hypothyroidism, catch-up growth may not be adequate to normalize adult height.    102\n",
       "Pediatric Use See WARNINGS and DOSAGE AND ADMINISTRATION .                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      97\n",
       "Pediatric Use When clindamycin hydrochloride is administered to the pediatric population (birth to 16 years), appropriate monitoring of organ system functions is desirable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    96\n",
       "8.4 Pediatric Use Pediatric use information for patients 7 to 17 years of age is approved for AstraZenecaâ€™s CRESTOR (rosuvastatin calcium) tablets. However, due to AstraZenecaâ€™s marketing exclusivity rights, this drug product is not labeled with that pediatric information.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               93\n",
       "Pediatric Use Because of the atropine-like side effects, benztropine mesylate should be used with caution in pediatric patients over three years of age (see CONTRAINDICATIONS ).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               85\n",
       "8.4 Pediatric Use Safety and effectiveness of simvastatin in patients 10 to 17 years of age with heterozygous familial hypercholesterolemia have been evaluated in a controlled clinical trial in adolescent boys and in girls who were at least 1 year post-menarche. Patients treated with simvastatin had an adverse reaction profile similar to that of patients treated with placebo. Doses greater than 40 mg have not been studied in this population . In this limited controlled study, there was no significant effect on growth or sexual maturation in the adolescent boys or girls, or on menstrual cycle length in girls. [See Dosage and Administration (2.5) , Adverse Reactions (6.1) , Clinical Studies (14.2) .] Adolescent females should be counseled on appropriate contraceptive methods while on simvastatin therapy [see Contraindications (4) and Use in Specific Populations (8.1) ]. Simvastatin has not been studied in patients younger than 10 years of age, nor in pre-menarchal girls.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         78\n",
       "Pediatric Use Little information is available about dosage in pediatric patients 4 years of age or younger (see CLINICAL PHARMACOLOGY and DOSAGE AND ADMINISTRATION sections for use in pediatric patients 4 to 18 years of age).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               74\n",
       "Name: pediatric_use, dtype: int64"
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "(df['pediatric_use'].\n",
    " dropna()[\n",
    "     ~df['pediatric_use'].\n",
    "     dropna().\n",
    "     str.\n",
    "     contains('have not been established')\n",
    " ].\n",
    " value_counts().\n",
    "head(10))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv('../../data/openfda_drug_labels_pediatric_table.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.7"
  },
  "toc": {
   "base_numbering": 1,
   "nav_menu": {},
   "number_sections": true,
   "sideBar": true,
   "skip_h1_title": false,
   "title_cell": "Table of Contents",
   "title_sidebar": "Contents",
   "toc_cell": false,
   "toc_position": {},
   "toc_section_display": true,
   "toc_window_display": true
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
